Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations

[1] Boekhout AH(2006)Symptoms and treatment in cancer therapy-induced early menopause Oncologist 11 641-654

[2] Beijnen JH(2004)Treatment of hot flashes in women with a previous diagnosis of breast cancer Bull Cancer 91 339-349

[3] Schellens JH(2006)Pathophysiology and management of hot flashes J Support Oncol 4 315-320

[4] Debourdeau P(2001)The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer J Pain Symptom Manag 22 979-989

[5] Bachelot T(1996)A menopause-specific quality of life questionnaire: development and psychometric properties Maturitas 24 161-175

[6] Zammit C(1996)The sexual activity questionnaire: a measure of women’s sexual functioning Qual Life Res 5 81-90

[7] Aletti M(1992)A new methodological approach to the evaluation of quality of life in postmenopausal women Maturitas 14 211-224

[8] Gallineau C(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial JAMA 288 321-333

[9] Gligorov J(2003)Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419-427

[10] Dalal S(2001)Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk J Clin Oncol 19 2357-2363

[1] Boekhout AH(2006)Symptoms and treatment in cancer therapy-induced early menopause Oncologist 11 641-654

[2] Beijnen JH(2004)Treatment of hot flashes in women with a previous diagnosis of breast cancer Bull Cancer 91 339-349

[3] Schellens JH(2006)Pathophysiology and management of hot flashes J Support Oncol 4 315-320

[4] Debourdeau P(2001)The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer J Pain Symptom Manag 22 979-989

[5] Bachelot T(1996)A menopause-specific quality of life questionnaire: development and psychometric properties Maturitas 24 161-175

[6] Zammit C(1996)The sexual activity questionnaire: a measure of women’s sexual functioning Qual Life Res 5 81-90

[7] Aletti M(1992)A new methodological approach to the evaluation of quality of life in postmenopausal women Maturitas 14 211-224

[8] Gallineau C(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial JAMA 288 321-333

[9] Gligorov J(2003)Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419-427

[10] Dalal S(2001)Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk J Clin Oncol 19 2357-2363